Related Experiment Video
Updated: May 23, 2026

Analysis of Congenital Heart Defects in Mouse Embryos Using Qualitative and Quantitative Histological Methods
Published on: March 10, 2020
Congenital heart disease affects cerebral size but not brain growth
Cynthia Ortinau1, Terrie Inder, Jennifer Lambeth
1Department of Pediatrics, St. Louis Children's Hospital, Washington University in St. Louis, St. Louis, MO 63110, USA. ortinau_c@kids.wustl.edu
Insights
Infants with congenital heart disease (CHD) show persistent brain size alterations at 3 months. However, their brain growth rates are similar to healthy infants, with somatic growth being a key factor.
Area of Science:
- Pediatric Cardiology
- Neuroscience
- Developmental Biology
Background:
- Congenital heart disease (CHD) is associated with delayed brain maturation and altered brain volumes in infants.
- Brain metrics offer a straightforward method for assessing infant brain development.
Purpose of the Study:
- To investigate if brain size alterations in infants with CHD persist at 3 months of age.
- To compare brain growth rates between infants with CHD and healthy controls.
Main Methods:
- Serial brain magnetic resonance imaging (MRI) was performed on 57 infants with CHD before surgery and at 3 months of age.
- Brain metrics were used to analyze 19 tissue and fluid spaces to evaluate brain growth.
- Somatic growth and white matter lesions were also assessed.
Main Results:
- Infants with CHD exhibited smaller frontal, parietal, and brainstem measures before surgery.
- These brain size alterations persisted at 3 months, except in the cerebellum.
- No significant differences in brain growth rates were observed between CHD and control infants; the cerebellum showed a trend towards greater growth in CHD infants.
- Somatic growth was the primary determinant of brain growth.
Conclusions:
- Infants with CHD have persistent brain size differences at 3 months, but their overall brain growth rates are comparable to healthy infants.
- Somatic growth is a critical factor influencing brain development in infants with CHD.
- Optimal weight gain is crucial for supporting brain growth in this population.
Abstract:
Infants with congenital heart disease (CHD) have delayed brain maturation and alterations in brain volume. Brain metrics is a simple measurement technique that can be used to evaluate brain growth. This study used brain metrics to test the hypothesis that alterations in brain size persist at 3 months of age and that infants with CHD have slower rates of brain growth than control infants. Fifty-seven infants with CHD underwent serial brain magnetic resonance imaging (MRI). To evaluate brain growth across the first 3 months of life, brain metrics were undertaken using 19 tissue and fluid spaces shown on MRIs performed before surgery and again at 3 months of age. Before surgery, infants with CHD have smaller frontal, parietal, cerebellar, and brain stem measures (p < 0.001). At 3 months of age, alterations persisted in all measures except the cerebellum. There was no difference between control and CHD infants in brain growth. However, the cerebellum trended toward greater growth in infants with CHD. Somatic growth was the primary factor that related to brain growth. Presence of focal white matter lesions before and after surgery did not relate to alterations in brain size or growth. Although infants with CHD have persistent alterations in brain size at 3 months of age, rates of brain growth are similar to that of healthy term infants. Somatic growth was the primary predictor of brain growth, emphasizing the importance of optimal weight gain in this population.
Related Concept Videos
Biological Influences on Intelligence
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cerebral Edema ll: Pathophysiology
Language and Cognition
Neurulation
Cerebrum: Anatomical Overview I

